Position in CRMD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$10,444,682
+$3,047,597 QoQ
Shares Held
1,538,245
+141.8% QoQ
Ownership
1.96%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. CRMD ranks #99 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in CRMD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,444,682 | 1,538,245 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $7,397,085 | 636,035 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $12,687,259 | 1,090,908 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,399,629 | 275,944 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,711,609 | 602,534 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,076,930 | 379,868 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $319,288 | 39,516 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $159,424 | 36,819 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $262,464 | 61,902 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $242,041 | 64,373 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $114,636 | 30,983 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $163,753 | 41,248 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $3,920 | 929 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $21,624 | 7,641 | Shares | Sole | 2022-11-10 | |
| 2022-03-31 | $55,889 | 10,199 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $83,300 | 18,308 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,970 | 4,725 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,688 | 975 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $96,643 | 9,674 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $54,298 | 7,308 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $24,258 | 4,023 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $63,182 | 10,029 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $55,088 | 15,345 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||